| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K27188169 |
| PharmacoGx | BRD-K27188169 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CXCL11 | CTRPv2 | pan-cancer | AAC | 0.39 | 9e-15 |
| mRNA | GSX1 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | FLT3 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-09 |
| mRNA | C3orf80 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | KY | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | IFNK | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | MMP9 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | OR4A16 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-06 |
| mRNA | GPR50 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | LDLRAD1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
